First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1-42) and aluminum -: A new insight in understanding Alzheimer's disease

被引:67
|
作者
Hegde, ML
Anitha, S
Latha, KS
Mustak, MS
Stein, R
Ravid, R
Rao, KSJ [1 ]
机构
[1] Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570013, Karnataka, India
[2] ITPL, Inst Biotechnol, Ctr Human Genet, Bangalore, Karnataka, India
[3] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Ramat Aviv, Israel
[4] Netherlands Brain Bank, Amsterdam, Netherlands
关键词
Alzheimer's disease; pUC18 supercoiled DNA; helical transitions; topoisomer separation; B-DNA; Z-DNA; psi-DNA;
D O I
10.1385/JMN:22:1-2:19
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we evidenced a B --> Z helical change in Alzheimer's brain genomic DNA, leading to a hypothesis that Alzheimer's disease (AD) etiological factors such as aluminum (Al), amyloid beta (Abeta) peptide, and Tau might play a role in modulating DNA topology. In the present study, we investigated the interaction of A1 and Abeta with DNA. Our results show that Abeta(1-42) could induce a B --> psi (Psi) conformational change in pUC 18 supercoiled DNA (scDNA), Abeta(1-16) caused an altered B-form, whereas A1 induced a complex B-C-A mixed conformation. Ethidium bromide binding and agarose gel electrophoresis studies revealed that A1 uncoiled the DNA to a fully relaxed form, whereas Abeta(1-42) and Abeta(1-16) effected a partial uncoiling and also showed differential sensitivity toward chloroquine-induced topoisomer separation. Our findings show for the first time that Abeta and A1 modulate both helicity and superhelicity in scDNA. A new hypothetical model explaining the potential toxicity of Abeta and A1 in terms of their DNA binding properties leading to DNA conformational alteration is proposed.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 50 条
  • [21] Decreased serum amyloid β1-42 autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide
    Brettschneider, S
    Morgenthaler, NG
    Teipel, SJ
    Fischer-Schulz, C
    Bürger, K
    Dodel, R
    Du, YS
    Möller, HJ
    Bergmann, A
    Hampel, H
    BIOLOGICAL PSYCHIATRY, 2005, 57 (07) : 813 - 816
  • [22] In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
    Yatin, SM
    Varadarajan, S
    Link, CD
    Butterfield, DA
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 325 - 330
  • [23] Amyloid β-Peptide (1-42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
    Butterfield, D. Allan
    Swomley, Aaron M.
    Sultana, Rukhsana
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (08) : 823 - 835
  • [24] Amyloid β-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain
    Butterfield, DA
    Boyd-Kimball, D
    BRAIN PATHOLOGY, 2004, 14 (04) : 426 - 432
  • [25] Simulation of the lipophilic and antigenic cores of the Aβ(1-42) peptide of Alzheimer's disease
    Mager, PP
    Fischer, K
    MOLECULAR SIMULATION, 2001, 27 (04) : 237 - 242
  • [26] Synthesis, aggregation, and neurotoxicity of the Alzheimer's Aβ1-42 amyloid peptide and its isoaspartyl isomers
    Fukuda, H
    Shimizu, T
    Nakajima, M
    Mori, H
    Shirasawa, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) : 953 - 956
  • [27] LYSOPHOSPHATIDYLCHOLINE INCREASES THE NEUROTOXICITY OF ALZHEIMER'S AMYLOID β1-42 PEPTIDE: ROLE OF OLIGOMER FORMATION
    Sheikh, A. Md.
    Michikawa, M.
    Kim, S. U.
    Nagai, A.
    NEUROSCIENCE, 2015, 292 : 159 - 169
  • [28] Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer's Amyloid β (Aβ1-42) Peptide
    Menon, Sneha
    Sengupta, Neelanjana
    ACS OMEGA, 2017, 2 (05): : 2134 - 2147
  • [29] The "O-acyl isopeptide method" for the synthesis of Alzheimer's disease-related amyloid β peptide (Aβ) 1-42
    Sohma, Y
    Kimura, M
    Chiyomori, Y
    Hayashi, Y
    Taniguchi, A
    Sasaki, M
    Kimura, T
    Kiso, Y
    BIOPOLYMERS, 2005, 80 (04) : 523 - 523
  • [30] Alzheimer's disease-related amyloid-β1-42 peptide induces the loss of human sperm function
    Tavares, R. S.
    Martins, S.
    Almeida-Santos, T.
    Sousa, A. P.
    Ramalho-Santos, J.
    da Cruz e Silva, O. A.
    CELL AND TISSUE RESEARCH, 2017, 369 (03) : 647 - 651